Deltex Medical Group plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DTXMF research report →
Companywww.deltexmedical.com
Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers esophageal Doppler Probes that is used to measure a patient's central vascular blood flow and fluid status to measure real time blood velocities within the descending aorta; Loops plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure waveform analysis algorithm used during periods of instability or for periods when the ODM mode is unavailable. The company also provides Deltex Medical Esophageal Doppler Simulator that enables clinicians to practice probe insertion, focusing, and waveform interpretation outside of a patient setting.
- CEO
- Natalie Emilia Wettler
- IPO
- 2009
- Employees
- 24
- HQ
- Chichester, GB
Price Chart
Valuation
- Market Cap
- $180.58M
- P/E
- -0.22
- P/S
- 0.37
- P/B
- 0.09
- EV/EBITDA
- -1.88
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 63.34%
- Op Margin
- -59.23%
- Net Margin
- -72.18%
- ROE
- -45.48%
- ROIC
- -19.24%
Growth & Income
- Revenue
- $2.06M · 15.77%
- Net Income
- $-1,797,000 · -40.17%
- EPS
- $-0.00 · 18.18%
- Op Income
- $-1,586,000
- FCF YoY
- 68.69%
Performance & Tape
- 52W High
- $0.10
- 52W Low
- $0.00
- 50D MA
- $0.10
- 200D MA
- $0.10
- Beta
- -2.28
- Avg Volume
- 29.26K
Get TickerSpark's AI analysis on DTXMF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our DTXMF Coverage
We haven't published any research on DTXMF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DTXMF Report →